Abstract
In the published article, there was an error. The unit of AUC used throughout the paper is incorrect. A correction has been made to the sections “Patients eligible for TDM and simulation for the calculated optimal dose,” (paragraph 3) “Therapeutic drug monitoring” (paragraph 2) and to the footnotes of Table 1. The unit for AUC previously stated: “AU*day/L” The corrected unit for AUC appears below: “AU*day/mL” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
| Original language | English |
|---|---|
| Article number | 1444228 |
| Journal | Frontiers in Pharmacology |
| Volume | 15 |
| DOIs |
|
| Publication status | Published - 6 Aug 2024 |
Keywords
- anti-thymocyte globulin (ATG)
- antibody
- pediatrics-children
- stem cell transplant (SCT)
- TDM (therapeutic drug monitoring)
Fingerprint
Dive into the research topics of 'Corrigendum: Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept (Front. Pharmacol., (2022), 13, (828094), 10.3389/fphar.2022.828094)'. Together they form a unique fingerprint.Research output
- 1 Article
-
Therapeutic Drug Monitoring of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation: Proof of Concept
Meesters-Ensing, J. I., Admiraal, R., Ebskamp, L., Lacna, A., Boelens, J. J., Lindemans, C. A. & Nierkens, S., 18 Mar 2022, In: Frontiers in Pharmacology. 13, p. 1-8 828094.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile12 Downloads (Pure)
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver